# Fluoptics

- Location (FDA's records): Grenoble Cedex 9, FR
- FDA decisions: 4 (2014–2023): 3 510(k) clearances and 1 De Novo grant
- Names in FDA's records: Fluoptics (3); Fluoptics Sas (1)
- Product codes: QDG (3), OWN (1)
- Predicates its devices cite: 1 (1 its own); citations of its devices by later devices: 7 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms that cite its devices most
- Fluoptics Sas (A Getinge Group Company): 2 (https://510kreport.com/company/fluoptics-a-getinge-group)
- MolecuLight, Inc.: 1 (https://510kreport.com/company/moleculight)
- Dendrite Imaging, Inc.: 1 (https://510kreport.com/company/dendrite-imaging)
- Quest Medical Imaging: 1 (https://510kreport.com/company/quest-medical-imaging)
- Novadaq Technologies, Inc.: 1 (https://510kreport.com/company/novadaq-technologies)

## Its most-cited devices
- K190891: Fluobeam LX (2019), cited by 3
- K132475: Fluobeam 800 Clinic Laser Imaging Device and Fluocase 800 Control System (2014), cited by 2
- DEN170092: Fluobeam 800 Clinic Imaging Device used with Fluocase 800 Control System (2018), cited by 1
- K230898: FLUOBEAM® LX Red (2023), cited by 1

## Recent decisions
- K230898: FLUOBEAM® LX Red (Jul 28, 2023)
- K190891: Fluobeam LX (Jul 31, 2019)
- DEN170092: Fluobeam 800 Clinic Imaging Device used with Fluocase 800 Control System (Nov 2, 2018)
- K132475: Fluobeam 800 Clinic Laser Imaging Device and Fluocase 800 Control System (May 7, 2014)

Source page: https://510kreport.com/company/fluoptics